Gina Clark - Mar 18, 2024 Form 4 Insider Report for Cencora, Inc. (COR)

Signature
/s/ Elizabeth S. Campbell, attorney-in-fact for Gina Clark
Stock symbol
COR
Transactions as of
Mar 18, 2024
Transactions value $
-$5,817,977
Form type
4
Date filed
5/31/2024, 04:00 PM
Previous filing
Feb 14, 2024
Next filing
Jun 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COR Common Stock Sale -$2.3M -9.64K -38.88% $238.12 15.2K Mar 18, 2024 Direct F1
transaction COR Common Stock Options Exercise $2.33M +27.1K +178.74% $86.09 42.3K May 29, 2024 Direct
transaction COR Common Stock Sale -$5.85M -27.1K -64.12% $216.07 15.2K May 29, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COR Non-qualified Stock Option (Right to Buy) Options Exercise $0 -27.1K -100% $0.00* 0 May 29, 2024 Common Stock 27.1K $86.09 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person effective 12/14/2023.
F2 The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $216.00 to $216.14, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
F3 Exercisable in four equal installments on 11/13/20, 11/13/21, 11/13/22 and 11/13/23.